Home Featured Page 267

Featured

Latest

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and Open Questions

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

The Psychedelic News Feed: January 05 – 11, 2026

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the...

MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create...

Red Light Holland Increases Points of Sale for iMicrodose Packs in...

Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica

Beckley Psytech partners with Fluence to create psychedelic therapy training programme

18-MC Has Unique Brain Functions and Mechanisms

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific...

Nova Mentis Organizes Autism Data Bank in North America

PT240 – Ralph Blumenthal – Alien Abductions and The Believer

Tryp Therapeutics Reports on Key Milestones for 2021

1...266267268...306 Page 267 of 306

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and...

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and Open Questions

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

The Psychedelic News Feed: January 05 – 11, 2026

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the...

MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create...

Red Light Holland Increases Points of Sale for iMicrodose Packs in...

Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica

Beckley Psytech partners with Fluence to create psychedelic therapy training programme

18-MC Has Unique Brain Functions and Mechanisms

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific...

Nova Mentis Organizes Autism Data Bank in North America

PT240 – Ralph Blumenthal – Alien Abductions and The Believer

Tryp Therapeutics Reports on Key Milestones for 2021

EDITOR PICKS

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and...

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY